Assess Lucrative Opportunities in Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Transdermal Skin Patch Applications Over the Forecast Period ...

The transdermal patches market is further segmented based on the patch type, adhesive type, application, distribution channel, end-user, and region. The Drug-In-Adhesives segment is expected to ...

The Buprenorphine Transdermal Patches Market has gained significant traction in recent years as a viable solution for managing chronic pain and opioid use disorder. Buprenorphine, a partial opioid ...

Atlanta-based Altea Therapeutics has inked a $46 million deal with Eli Lilly and Amylin Pharmaceuticals to develop and commercialize a daily transdermal patch delivering sustained levels of Byetta ...

Marketresearch.biz reports that the Transdermal Patches Market size is expected to be worth around USD 11.7 Bn by 2032 from USD 7.4 Bn in 2022, growing at a CAGR of 4.8% during the forecast period ...

TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...

Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Transdermal Skin Patches Market by Types, Application, Distribution Channel, and Region with Company Analysis 2025-2033" report has been added to ...